Sudarshan Pharma Industries バランスシートの健全性
財務の健全性 基準チェック /26
Sudarshan Pharma Industries has a total shareholder equity of ₹1.2B and total debt of ₹1.2B, which brings its debt-to-equity ratio to 105.6%. Its total assets and total liabilities are ₹3.2B and ₹2.0B respectively. Sudarshan Pharma Industries's EBIT is ₹294.2M making its interest coverage ratio 2.6. It has cash and short-term investments of ₹19.2M.
主要情報
105.6%
負債資本比率
₹1.24b
負債
| インタレスト・カバレッジ・レシオ | 2.6x |
| 現金 | ₹19.17m |
| エクイティ | ₹1.18b |
| 負債合計 | ₹2.03b |
| 総資産 | ₹3.20b |
財務の健全性に関する最新情報
更新なし
Recent updates
財務状況分析
短期負債: 543828's short term assets (₹2.6B) exceed its short term liabilities (₹1.9B).
長期負債: 543828's short term assets (₹2.6B) exceed its long term liabilities (₹95.9M).
デット・ツー・エクイティの歴史と分析
負債レベル: 543828's net debt to equity ratio (104%) is considered high.
負債の削減: 543828's debt to equity ratio has increased from 91.5% to 105.6% over the past 5 years.
債務返済能力: 543828's debt is not well covered by operating cash flow (4.8%).
インタレストカバレッジ: 543828's interest payments on its debt are not well covered by EBIT (2.6x coverage).